600721.SH
Xinjiang Baihuacun Pharam Tech Co., Ltd.
SSE · Consumer Cyclical · Restaurants · CN
CNY 9.19
+1.66%Sep 28, 2026, 13:27 UTC
Baihua Pharmaceutical (600721) fell 5.73% on September 28, 2026 with a 26.06% turnover rate and RMB 1.231 billion in trading value, triggering a Shanghai Stock Exchange dragon-tiger list appearance.
Source:Sep 10, 2026, 09:28 UTC
Baihua Pharmaceutical elected Chen Yinkai as chairman of its 10th board of directors and appointed Qian Shugang as general manager, along with several other senior management appointments.
Source:Aug 24, 2026, 11:14 UTC
Baihua Pharmaceutical announced its 2026 first-half results: revenue of 157 million yuan, down 22.13% year-on-year; net profit attributable to shareholders of 14.76 million yuan, down 42.08% year-on-year.
Source: